Article Image
IPFS News Link • Vaccines and Vaccinations

COVID-19 Vaccines: Continuing the Long History of Medical Experimentation on Children

• Childrens Health Defense Team

First, the entities rushing to develop an experimental chimpanzee-derived COVID-19 injection—the conflict-of-interest-ridden Oxford Vaccine Group, Oxford's Jenner Institute and pharmaceutical giant AstraZeneca—announced the imminent expansion of their clinical trials to a wider age range, including children aged 5 to 12 years, despite  "troubling results" when they administered the vaccine to rhesus monkeys. Endorsing the scale-up of the experiment to more than 30,000 eventual participants, including a trial to evaluate the vaccine in young children, the U.S. Department of Health and Human Services (HHS) immediately awarded a generous "$1.2 billion cash injection" for the UK effort (provided without any input from economically strapped American taxpayers). Then, to cap the day off, a UK Court of Appeal ominously ruled that local authorities can vaccinate children in foster care against their parents' wishes, deploying the argument that "it is in the best interests of children to be immunised unless there is a specific reason for them not to be."

Anyone who has been paying a modicum of attention knows where the vaccine cartel wants this to end up—with a mandated injection that will sneak high-risk gene-altering nanoparticles, Trojan-horse-style, into our children, and eventually, into all of us. However, the use of children as a wedge to implement mandates for adults—the age group most affected by COVID-19—would deny children the equal protection of law because the vaccine will not be primarily for their benefit.

A first step on this slippery slope will be to persuade unwitting parents to offer up their children on the altar of COVID-19 vaccine experimentation. It is unclear how the researchers will go about convincing parents to take this step, particularly because the most recent evidence—a systematic review of 45 scientific papers and letters—confirms that children account for only 1% to 5% of diagnosed COVID-19 cases and experience a milder course of disease, a better prognosis than adults, and death "extremely" rarely. Subjecting children to the hazards of clinical trials for a risk this low is perverse.


thelibertyadvisor.com/declare